ACE2 and COVID-19: Figure 9 depicts the working summary of this study for epigenetic evolution and regulation of IL-6 and ACE2 as non-ISGs, indicating their potentials as biomarkers for inflammatory syndrome underlying pathogenic viral infection such as of COVID-19.